[1]Gallinari P, Dimarco S, Jones P, et al.HDACs, histone deacetyla-tion and gene transcription:from molecular biology to cancer ther-apeutics[J].Cell Res, 2007, 17 (3) :195-211.
|
[2] Poon D, Anderson BO, Chen LT, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009[J]. Lancet Oncol, 2009, 10 (11) : 1111-1118.
|
[3] Mariadason JM. HDACs and HDAC inhibitors in colon cancer[J]. Epigenetics, 2008, 3 (1) : 1-10.
|
[4] Bertrand P. Inside HDAC with HDAC inhibitors[J].Eur J Medchem, 2010, 45 (6) : 2095-2116.
|
[5] Taunton J. Hassig CA, Schreiber SL. A mammalion histone deacetylase related to the yeast transcriptional regulator Rpd3p[J]. Science, 1996, 272 (5) : 408-411.
|
[6]Rikimaru T, Taketomi A, Yamashita Y, et al.Clinical significance of histone deacetylase1expression in patients with hepatocel-lular carcinoma[J].Oncology, 2007, 72 (1-2) :69-74.
|
[7]Yoo YG, Na TY, Seo HW, et al.Hepatitis B virus X protein induces the expression of MTA1and HDAC1, which en-hances hypoxia signaling in hepatocellular carcinoma cells[J].Oncogene, 2008, 27 (24) :3405-3413.
|
[8] Zopf S, Neureiter D, Bouralexis S, et al. Differential response of p53 and p21 on HDAC inhibitor mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo [J]. Int Oncol, 2007, 31 (16) :1391-1402.
|
[9] Giannelli G, Bergamini C, Marinosci F, et al. Clinical role of MMP-2/ TIMP-2 imbalance in hepatocellular carcinoma[J]. Int J Cancer, 2002, 97 (4) :425-431.
|
[10]whetstine JR, Ceron J, Ladd B, et al.Regulation of tissue specific and extracellular matrix-related genes by a class1 histone deacetylase[J].Mol Cell, 2005, 18 (4) :483-490.
|